This Philly-based company is using AI to predict which medical research can lead to profitable drugs and therapies Clarivate ...

Drug prices in the United States are astronomical and climbing. Many analysts blame mergers and acquisitions among ...

Regeneron Pharmaceuticals said it would acquire 23andMe, which filed for bankruptcy in March and would continue to offer ...

An Enquirer analysis found that doctors, nurses and other practitioners received $136 million from pharma and biotech ...

It will acquire genetic data of more than 15 million customers – raising privacy concerns from individuals who had willingly ...

The White House has released its long-awaited “MAHA Report” outlining the government’s target areas for addressing childhood ...

Big Pharma is using dark money to fund groups that sound like patient advocacy organizations but represent the industry.

RAMAT GAN, Israel (AP) — RAMAT GAN, Israel (AP) — Galmed Pharmaceuticals Ltd. (GLMD) on Thursday reported a loss of $1.1 million in its first quarter. On a per-share basis, the Ramat Gan, Israel-based ...

Global pharmaceutical giant Eli Lilly & Co. is seeking tax incentives for a potential 236-acre biomanufacturing plant in ...

Bristol Myers CEO Christopher Boerner advocates global cost-sharing for drug R&D and criticizes PBMs. Read nore here.

Genetic testing company 23andMe filed for Chapter 11 bankruptcy protection in March. Regeneron Pharmaceuticals announced it ...

Regeneron is acquiring “substantially all” of 23andMe’s assets for $256 million following a bankruptcy auction.